![](/img/cover-not-exists.png)
Nebulized arformoterol in patients with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial
Rudolf A. Baumgartner, Nicola A. Hanania, William J. Calhoun, Steven A. Sahn, Kenneth Sciarappa, John P. HanrahanVolume:
29
Year:
2007
Language:
english
Pages:
279
DOI:
10.1016/j.clinthera.2007.02.009
File:
PDF, 1.12 MB
english, 2007